Home / Companies / Pharm Co Rx / Trends
Pharm Co Rx H-1B trends
Quarterly LCA aggregate trend points for Pharm Co Rx. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Pharm Co Rx span 2021 Q3 to 2024 Q3, peaking at 1 filings in 2021 Q3.
The most recent reported period (2024 Q3) shows 1 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2021 Q3 | 1 | 1 | 1 | $70,000 | $57,741 | 1 | 100.0% |
| 2024 Q3 | 1 | 1 | 1 | $115,000 | $113,589 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Pharm Co Rx changed over time?
- H-1B LCA filings for Pharm Co Rx span 2021 Q3 to 2024 Q3, peaking at 1 filings in 2021 Q3. The most recent reported period (2024 Q3) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=pharm+co+rx&metric=lca_countJSON